Question 1

What are the best models for delivering long-term cancer care including screening, diagnosing and managing long-term side effects and late-effects of cancer and its treatment (e.g. primary and secondary care, voluntary organisations, self-management, carer involvement, use of digital technology, etc)?
Read More

Below are examples of questions people submitted to us which we then merged into the above research question.

Models for delivering long-term cancer care is important to me because we need more services in the community. More research is needed to understand what works so that people can benefit from support that is closer to where they live.
What is the role of community pharmacy in supporting patients living with or beyond cancer?
What would patients like to see in a cancer care review in primary care and at what point does a patient feel it would be appropriate to have a review of their cancer and treatment by their GP?
Post treatment surveillance strategies: the number of cancer survivors is rising and becoming a strain on resources (clinician time in particular). With increasingly reliable detection tools such as circulating tumour DNA (ctDNA, liquid biopsy), and smart phones, could patients monitor themselves using AI (artificial intelligence)? Self-directed post treatment surveillance?